➀ Researchers at the University of Ottawa have developed a new contrast agent for IV-OCT, using gold superclusters (AuSC) to enhance imaging clarity. ➁ The team coated the AuSC with a special polymer for stability and targeted imaging. ➂ The new agent, AuSC@(13FS)2, binds to P-selectin and improves IV-OCT imaging, potentially leading to personalized heart disease treatments.
Related Articles
- Loughborough University Physicists Create ‘The World’s Smallest Violin’ Using Nanotechnology2 days ago
- Light-Driven Plasmonic Microrobots for Nanoparticle Manipulation2 months ago
- Engineered Nanoclusters for Enhanced Stability in Hydrogen Evolution2 months ago
- Nanotechnology Could Improve Odds in Treating Aggressive Breast Cancers2 months ago
- Iron-Doped Boron Nitride Nanoparticles for Targeted Anastrozole Delivery3 months ago
- Advancing Ultra-Sensitive Health Monitoring3 months ago
- ATLANT 3D Secures $15 M Series A+ as Demand Grows for its Atomic Layer Processing Technology3 months ago
- Bioinspired Nanoscale 3D Printing of Calcium Phosphates3 months ago
- Controlling Light Color and Frequency for Advanced Technologies3 months ago
- Empa's New 'CarboQuant' Lab Peers into Carbon's (Quantum-) World3 months ago